C-C Motif Chemokine Ligand 2 and Chemokine Receptor 2 in Cardiovascular and Neural Aging and Aging-Related Diseases

被引：0

作者：

Guo, David ^{[1
]}

Zhu, Wuqiang ^{[2
]}

Qiu, Hongyu ^{[1
,3
]}

机构：

[1] Univ Arizona, Coll Med Phoenix, Cardiovasc Translat Res Ctr, Dept Internal Med, Phoenix, AZ 85004 USA

[2] Mayo Clin Arizona, Ctr Regenerat Biotherapeut, Dept Cardiovasc Med Physiol & Biomed Engn, Scottsdale, AZ 85259 USA

[3] Univ Arizona, Clin Translat Sci CTS & Inst Bio5, Tucson, AZ 85721 USA

来源：

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2024年 / 25卷 / 16期

关键词：

aging; CCL2/CCR2; inflammation; cardiovascular diseases; neural; cancer; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; AMYLOID-BETA; CCR2; CCL2; DEFICIENCY; ACTIVATION; EXPRESSION; MONOCYTES; MECHANISMS; MACROPHAGE;

D O I：

10.3390/ijms25168794

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Aging is a prominent risk factor for numerous chronic diseases. Understanding the shared mechanisms of aging can aid in pinpointing therapeutic targets for age-related disorders. Chronic inflammation has emerged as a pivotal mediator of aging and a determinant in various age-related chronic conditions. Recent findings indicate that C-C motif chemokine ligand 2 and receptor 2 (CCL2-CCR2) signaling, an important physiological modulator in innate immune response and inflammatory defense, plays a crucial role in aging-related disorders and is increasingly recognized as a promising therapeutic target, highlighting its significance. This review summarizes recent advances in the investigation of CCL2-CCR2 signaling in cardiovascular and neural aging, as well as in various aging-related disorders. It also explores the underlying mechanisms and therapeutic potentials in these contexts. These insights aim to deepen our understanding of aging pathophysiology and the development of aging-related diseases.

引用

页数：16

共 92 条

[1] CCR2 receptor blockade alters blood monocyte subpopulations but does not affect atherosclerotic lesions in apoE-/- mice [J].

Aiello, Robert J. ;

Perry, Bret D. ;

Bourassa, Patricia-Ann ;

Robertson, Andrew ;

Weng, Weifan ;

Knight, Delvin R. ;

Smith, Andrew H. ;

Frederick, Kosea S. ;

Kalgutkar, Amit ;

Gladue, Ronald P. .

ATHEROSCLEROSIS, 2010, 208 (02) :370-375

[2] Inflammaging: mechanisms and role in the cardiac and vasculature [J].

Ajoolabady, Amir ;

Pratico, Domenico ;

Vinciguerra, Manlio ;

Lip, Gregory Y. H. ;

Franceschi, Claudio ;

Ren, Jun .

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2023, 34 (06) :373-387

[3] Aging and the immune system: An overview [J].

Akha, Amir A. Sadighi .

JOURNAL OF IMMUNOLOGICAL METHODS, 2018, 463 :21-26

[4] Inflammaging: Implications in Sarcopenia [J].

Antuna, Eduardo ;

Cachan-Vega, Cristina ;

Carlos Bermejo-Millo, Juan ;

Potes, Yaiza ;

Caballero, Beatriz ;

Vega-Naredo, Ignacio ;

Coto-Montes, Ana ;

Garcia-Gonzalez, Claudia .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)

[5] International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors [J].

Bachelerie, Francoise ;

Ben-Baruch, Adit ;

Burkhardt, Amanda M. ;

Combadiere, Christophe ;

Farber, Joshua M. ;

Graham, Gerard J. ;

Horuk, Richard ;

Sparre-Ulrich, Alexander Hovard ;

Locati, Massimo ;

Luster, Andrew D. ;

Mantovani, Alberto ;

Matsushima, Kouji ;

Murphy, Philip M. ;

Nibbs, Robert ;

Nomiyama, Hisayuki ;

Power, Christine A. ;

Proudfoot, Amanda E. I. ;

Rosenkilde, Mette M. ;

Rot, Antal ;

Sozzani, Silvano ;

Thelen, Marcus ;

Yoshie, Osamu ;

Zlotnik, Albert .

PHARMACOLOGICAL REVIEWS, 2014, 66 (01) :1-79

[6] Inhibition of inflammatory CCR2 signaling promotes aged muscle regeneration and strength recovery after injury [J].

Blanc, Romeo S. ;

Kallenbach, Jacob G. ;

Bachman, John F. ;

Mitchell, Amanda ;

Paris, Nicole D. ;

Chakkalakal, Joe V. .

NATURE COMMUNICATIONS, 2020, 11 (01)

[7] CCR2 deficiency leads to increased eosinophils, alternative macrophage activation, and type 2 cytokine expression in adipose tissue [J].

Bolus, W. Reid ;

Gutierrez, Dario A. ;

Kennedy, Arion J. ;

Anderson-Baucum, Emily K. ;

Hasty, Alyssa H. .

JOURNAL OF LEUKOCYTE BIOLOGY, 2015, 98 (04) :467-477

[8] Murine macrophage chemokine receptor CCR2 plays a crucial role in macrophage recruitment and regulated inflammation in wound healing [J].

Boniakowski, Anna E. ;

Kimball, Andrew S. ;

Joshi, Amrita ;

Schaller, Matt ;

Davis, Frank M. ;

denDekker, Aaron ;

Obi, Andrea T. ;

Moore, Bethany B. ;

Kunkel, Steve L. ;

Gallagher, Katherine A. .

EUROPEAN JOURNAL OF IMMUNOLOGY, 2018, 48 (09) :1445-1455

[9] A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy [J].

Bot, Ilze ;

Zacarias, Natalia V. Ortiz ;

de Witte, Wilhelmus E. A. ;

de Vries, Henk ;

van Santbrink, Peter J. ;

van der Velden, Daniel ;

Kroner, Mara J. ;

van der Berg, Dirk-Jan ;

Stamos, Dean ;

de Lange, Elizabeth C. M. ;

Kuiper, Johan ;

IJzerman, Adriaan P. ;

Heitman, Laura H. .

SCIENTIFIC REPORTS, 2017, 7

[10] Hypertension and aging [J].

Buford, Thomas W. .

AGEING RESEARCH REVIEWS, 2016, 26 :96-111

← 1 2 3 4 5 6 7 8 9 10 →